Acute respiratory and cardiovascular admissions after a public smoking ban in Geneva, Switzerland.

Acute respiratory and cardiovascular admissions after a public smoking ban in Geneva, Switzerland.

Blog Article

BackgroundMany countries have introduced legislations for public smoking bans to reduce the harmful effects of exposure to tobacco smoke.Smoking bans cause significant reductions in admissions for acute coronary syndromes but their impact on respiratory diseases is unclear.In Geneva, Switzerland, two popular votes led to a stepwise implementation of a state smoking ban in public places, with a temporary suspension.This study evaluated the effect of this smoking ban on hospitalisations for acute respiratory and cardiovascular diseases.MethodsThis before and after intervention study was conducted at the University Hospitals of Geneva, Switzerland, across 4 periods with different smoking legislations.

It included 5,345 patients with a first hospitalisation for acute coronary syndrome, ischemic stroke, acute citroen c4 picasso boot liner exacerbation of chronic obstructive pulmonary disease, pneumonia and acute asthma.The main outcomes were the incidence rate ratios (IRR) of admissions for each diagnosis after the final ban compared to the pre-ban period and adjusted for age, gender, season, influenza epidemic and secular trend.ResultsHospitalisations for acute exacerbation of chronic obstructive pulmonary disease significantly decreased over the 4 periods and were lowest after the final ban (IRR=0.54 [95%CI: 0.42-0.

68]).We cc-330 husky aircraft observed a trend in reduced admissions for acute coronary syndromes (IRR=0.90 [95%CI: 0.80-1.00]).

Admissions for ischemic stroke, asthma and pneumonia did not significantly change.ConclusionsA legislative smoking ban was followed by a strong decrease in hospitalisations for acute exacerbation of chronic obstructive pulmonary disease and a trend for reduced admissions for acute coronary syndrome.Smoking bans are likely to be very beneficial for patients with chronic obstructive pulmonary disease.